4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with antipyrine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, K; Ishida, J; Iwashita, A; Matsuoka, N; Mihara, K; Yamamoto, H | 1 |
1 other study(ies) available for 4-phenyl-1,2,3,6-tetrahydropyridine and antipyrine
Article | Year |
---|---|
4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Antipyrine; Benzamides; Humans; Inhibitory Concentration 50; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship | 2005 |